Management of Ferritin 7.2 ng/mL
A ferritin of 7.2 ng/mL represents severe iron deficiency that requires immediate iron replacement therapy and gastrointestinal evaluation to identify the underlying cause. 1
Diagnostic Confirmation
This ferritin level is well below any diagnostic threshold for iron deficiency. The 2020 AGA guidelines establish that ferritin <45 ng/mL has 85% sensitivity and 92% specificity for iron deficiency, while even the older threshold of <15 ng/mL has 99% specificity 1. Your patient's level of 7.2 ng/mL is unequivocally diagnostic—this represents depleted iron stores with active iron-deficient erythropoiesis 2.
Immediate Management Steps
1. Initiate Iron Replacement
Start oral iron supplementation immediately 3:
- Ferrous sulfate, ferrous fumarate, or ferrous gluconate are reasonable first-line choices (least expensive)
- Take on an empty stomach when possible for better absorption
- If not tolerated, take with meals (preferably with meat protein)
- Add 500 mg vitamin C to enhance absorption even with food 3
Consider intravenous iron if:
- Severe symptoms are present
- Oral iron is not tolerated
- Conditions exist that impair absorption (celiac disease, inflammatory bowel disease, H. pylori infection)
- Rapid repletion is needed 3
2. Gastrointestinal Evaluation
For postmenopausal women and men: The AGA strongly recommends bidirectional endoscopy (both EGD and colonoscopy) performed at the same setting 1. This is a strong recommendation with moderate-quality evidence, as gastrointestinal blood loss is the most common cause in these populations.
For premenopausal women: First assess menstrual blood loss and dietary intake before proceeding to endoscopy, unless alarm symptoms are present.
3. Additional Workup
Evaluate for:
- Dietary iron intake (vegetarian/vegan diet, inadequate meat consumption)
- Menstrual history in premenopausal women
- Helicobacter pylori infection (can impair iron absorption)
- Celiac disease (tissue transglutaminase antibodies)
- Inflammatory bowel disease
- Chronic blood loss (NSAIDs, anticoagulants, occult bleeding) 3
Treatment Targets
Goal ferritin levels:
- Normalize to >100 ng/mL in most conditions 4
- The 2024 AGA update recommends ferritin 45-100 ng/mL as adequate for most patients 3
- Hemoglobin target: 10-12 g/dL or normalization 4
Critical Pitfalls to Avoid
Do not delay gastrointestinal evaluation while treating with iron—the underlying cause must be identified, particularly in postmenopausal women and men where malignancy is a concern 1
Do not use ferritin alone in inflammatory conditions—if C-reactive protein is elevated or chronic disease is present, add transferrin saturation (<20% suggests true iron deficiency) or soluble transferrin receptor 1, 3
Do not assume dietary deficiency alone in postmenopausal women or men—gastrointestinal pathology must be excluded 1
Monitor response to therapy—recheck ferritin and hemoglobin in 4-8 weeks. Failure to respond suggests ongoing blood loss, malabsorption, or need for IV iron 3
Special Considerations
If celiac disease is diagnosed, ensure strict gluten-free diet adherence before expecting improvement in iron absorption 3. If small bowel bleeding is suspected after negative bidirectional endoscopy, deep enteroscopy with distal attachment should be performed to detect and treat angioectasias 3.
The severity of this ferritin level (7.2 ng/mL) indicates this patient has progressed beyond simple depletion to active impairment of red blood cell production, making both diagnosis of the underlying cause and aggressive iron repletion urgent priorities.